BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20723539)

  • 1. IL-4-mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways.
    Wang J; Hu Y; Nekvindova J; Ingelman-Sundberg M; Neve EP
    Biochem Pharmacol; 2010 Nov; 80(10):1592-600. PubMed ID: 20723539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4 regulates chemokine CCL26 in keratinocytes through the Jak1, 2/Stat6 signal transduction pathway: Implication for atopic dermatitis.
    Bao L; Shi VY; Chan LS
    Mol Immunol; 2012 Feb; 50(1-2):91-7. PubMed ID: 22226123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.
    Liddiard K; Welch JS; Lozach J; Heinz S; Glass CK; Greaves DR
    BMC Mol Biol; 2006 Nov; 7():45. PubMed ID: 17134490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells.
    So EY; Oh J; Jang JY; Kim JH; Lee CE
    Mol Immunol; 2007 Jul; 44(13):3416-26. PubMed ID: 17433443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of interleukin-4-responsive region in the human cytochrome P450 2E1 gene promoter.
    Abdel-Razzak Z; Garlatti M; Aggerbeck M; Barouki R
    Biochem Pharmacol; 2004 Oct; 68(7):1371-81. PubMed ID: 15345327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter.
    Messner B; Stütz AM; Albrecht B; Peiritsch S; Woisetschläger M
    J Immunol; 1997 Oct; 159(7):3330-7. PubMed ID: 9317131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
    Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
    Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of the IL31 gene by NFAT and STAT6.
    Park K; Park JH; Yang WJ; Lee JJ; Song MJ; Kim HP
    J Leukoc Biol; 2012 Feb; 91(2):245-57. PubMed ID: 22045870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 up-regulation of epidermal interleukin-19 expression in keratinocytes involves the binding of signal transducer and activator of transcription 6 (Stat6) to the imperfect Stat6 sites.
    Bao L; Alexander JB; Shi VY; Mohan GC; Chan LS
    Immunology; 2014 Dec; 143(4):601-8. PubMed ID: 24943510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stat6 inhibits human interleukin-4 promoter activity in T cells.
    Georas SN; Cumberland JE; Burke TF; Chen R; Schindler U; Casolaro V
    Blood; 1998 Dec; 92(12):4529-38. PubMed ID: 9845517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
    Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
    Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PU.1 is required for transcriptional activation of the Stat6 response element in the Igepsilon promoter.
    Pesu M; Aittomäki S; Välineva T; Silvennoinen O
    Eur J Immunol; 2003 Jun; 33(6):1727-35. PubMed ID: 12778491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6.
    Ohmori Y; Smith MF; Hamilton TA
    J Immunol; 1996 Sep; 157(5):2058-65. PubMed ID: 8757327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
    Natoli A; Lüpertz R; Merz C; Müller WW; Köhler R; Krammer PH; Li-Weber M
    Int J Cancer; 2013 Oct; 133(8):1945-54. PubMed ID: 23553437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2.
    Peng HM; Coon MJ
    Arch Biochem Biophys; 2000 Oct; 382(1):129-37. PubMed ID: 11051106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of IL-4-mediated up-regulation of the polymeric Ig receptor: role of STAT6 in cell type-specific delayed transcriptional response.
    Schjerven H; Brandtzaeg P; Johansen FE
    J Immunol; 2000 Oct; 165(7):3898-906. PubMed ID: 11034397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of chemokine expression by Th1 and Th2 cytokines and mechanisms of eotaxin/CCL-11 expression in human airway smooth muscle cells.
    Odaka M; Matsukura S; Kuga H; Kokubu F; Kasama T; Kurokawa M; Kawaguchi M; Ieki K; Suzuki S; Watanabe S; Homma T; Takeuchi H; Nohtomi K; Schleimer RP; Adachi M
    Int Arch Allergy Immunol; 2007; 143 Suppl 1(Suppl 1):84-8. PubMed ID: 17541284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-4 downregulates TNFalpha-induced IL-8 production in keratinocytes.
    Raingeaud J; Pierre J
    FEBS Lett; 2005 Jul; 579(18):3953-9. PubMed ID: 16004996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 modulates transcriptional control of the mannose receptor in mouse FSDC dendritic cells.
    Egan BS; Abdolrasulnia R; Shepherd VL
    Arch Biochem Biophys; 2004 Aug; 428(2):119-30. PubMed ID: 15246867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.